It sounds like Epocrates is focusing on delivering mobile apps for 3 major smartphone operating systems: iPhone, Android, and BlackBerry.
Given that other operating systems like webOS and Windows Mobile are rapidly losing traction, I can understand why they'd make this decision.
Fortunately, the web-based version of Epocrates (found here: http://online.epocrates.com/) is optimized for the majority of mobile browsers, so you always access drug information using that method. Eventually, we'll see fewer mobile apps as things move to mobile browser-based "apps."
No comments:
Post a Comment